Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224529703> ?p ?o ?g. }
- W4224529703 endingPage "e228788" @default.
- W4224529703 startingPage "e228788" @default.
- W4224529703 abstract "<h3>Importance</h3> In China, little is known about end-of-life (EOL) care preferences of patients with terminal cancer. Understanding these patients’ treatment preferences is needed to improve patient-centered health care, better inform surrogates and medical staff about patient preferences, and enhance the quality of EOL care. <h3>Objective</h3> To examine preferences for EOL care among patients with terminal cancer in China. <h3>Design, Setting, and Participants</h3> In this survey study, patients older than 50 years who had terminal cancer were randomly selected from medical records at a single hospital in China. Data on patients’ EOL care preferences were collected by discrete choice experiment (DCE) from August to November 2018 and were analyzed from October 2020 to March 2021. <h3>Main Outcomes and Measures</h3> The main outcome was patient preferences in EOL care, derived using a mixed logit model. Each DCE scenario described 6 attributes: hospitalization days, life extension, quality of life, adverse treatment events, place-of-death preference, and out-of-pocket costs. The marginal willingness to pay (WTP) in US dollars was estimated from regression coefficients. <h3>Results</h3> Of 188 patients selected for the survey, 183 participated (97.3%). Among the respondents, the mean [SD] age was 61 [8.4] years, and 128 (69.8%) were male. Patients’ preferences for moderate increase in survival time, better quality of life, death at home, and lower out-of-pocket costs were significantly associated with their choices between treatment models. Extending life by 10 months (vs 4 months: β, 1.63; 95% CI, 0.81-2.44) and a better quality of life (very good vs poor: β, 1.79; 95% CI, 0.96-2.62) were the most important attributes to patients. The uptake rate for a treatment scenario increased by 61.6% when the quality of life improved from poor to very good, and when life extension increased from 4 months to 10, the uptake rate increased by 57.2%. The uptake increased by 12.5% when the place of death changed from hospital to home. However, it decreased by 31.4% when the costs increased to $21 174. The study found a WTP of $38 854 (95% CI, $19 468-$95 096) to improve quality of life from a poor to a very good level, substantially higher than the WTP for a life extension of 6 months ($35 308; 95% CI, $17 745-$80 279) or 1 year ($27 572; 95% CI, $16 389-$58 027) compared with the baseline scenario of a 4-month extension. Patients were willing to pay $8860 (95% CI, $621-$26 474) to die at home rather than in a hospital. <h3>Conclusions and Relevance</h3> The findings suggest that in addition to extending life moderately for patients with terminal cancer, improving quality of life during EOL care and supporting home deaths may deserve greater attention. The findings also suggest that physicians and surrogates should ask about patients’ care preferences and better inform them of their choices to improve EOL care outcomes." @default.
- W4224529703 created "2022-04-27" @default.
- W4224529703 creator A5008221780 @default.
- W4224529703 creator A5023240641 @default.
- W4224529703 creator A5024428192 @default.
- W4224529703 creator A5032764121 @default.
- W4224529703 creator A5035542029 @default.
- W4224529703 creator A5075969066 @default.
- W4224529703 date "2022-04-25" @default.
- W4224529703 modified "2023-10-02" @default.
- W4224529703 title "Preferences for End-of-Life Care Among Patients With Terminal Cancer in China" @default.
- W4224529703 cites W1736458879 @default.
- W4224529703 cites W1759695215 @default.
- W4224529703 cites W1954335666 @default.
- W4224529703 cites W1992100496 @default.
- W4224529703 cites W1992329672 @default.
- W4224529703 cites W2024305803 @default.
- W4224529703 cites W2041912042 @default.
- W4224529703 cites W2042222676 @default.
- W4224529703 cites W2057700775 @default.
- W4224529703 cites W2100910330 @default.
- W4224529703 cites W2102015862 @default.
- W4224529703 cites W2104868554 @default.
- W4224529703 cites W2110636701 @default.
- W4224529703 cites W2112753493 @default.
- W4224529703 cites W2114882522 @default.
- W4224529703 cites W2118493650 @default.
- W4224529703 cites W2134885646 @default.
- W4224529703 cites W2165538120 @default.
- W4224529703 cites W2272984102 @default.
- W4224529703 cites W2302693759 @default.
- W4224529703 cites W2306108151 @default.
- W4224529703 cites W2340942586 @default.
- W4224529703 cites W2367707061 @default.
- W4224529703 cites W2585305138 @default.
- W4224529703 cites W2599859019 @default.
- W4224529703 cites W2790114565 @default.
- W4224529703 cites W2805450961 @default.
- W4224529703 cites W2910294144 @default.
- W4224529703 cites W2947158824 @default.
- W4224529703 cites W2973816978 @default.
- W4224529703 cites W2981596557 @default.
- W4224529703 cites W3015026866 @default.
- W4224529703 cites W3144431626 @default.
- W4224529703 cites W3191034548 @default.
- W4224529703 cites W3191422622 @default.
- W4224529703 cites W4237310018 @default.
- W4224529703 cites W4238846976 @default.
- W4224529703 cites W4249876930 @default.
- W4224529703 doi "https://doi.org/10.1001/jamanetworkopen.2022.8788" @default.
- W4224529703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35467732" @default.
- W4224529703 hasPublicationYear "2022" @default.
- W4224529703 type Work @default.
- W4224529703 citedByCount "7" @default.
- W4224529703 countsByYear W42245297032022 @default.
- W4224529703 countsByYear W42245297032023 @default.
- W4224529703 crossrefType "journal-article" @default.
- W4224529703 hasAuthorship W4224529703A5008221780 @default.
- W4224529703 hasAuthorship W4224529703A5023240641 @default.
- W4224529703 hasAuthorship W4224529703A5024428192 @default.
- W4224529703 hasAuthorship W4224529703A5032764121 @default.
- W4224529703 hasAuthorship W4224529703A5035542029 @default.
- W4224529703 hasAuthorship W4224529703A5075969066 @default.
- W4224529703 hasBestOaLocation W42245297031 @default.
- W4224529703 hasConcept C121608353 @default.
- W4224529703 hasConcept C126322002 @default.
- W4224529703 hasConcept C144024400 @default.
- W4224529703 hasConcept C149923435 @default.
- W4224529703 hasConcept C151956035 @default.
- W4224529703 hasConcept C159110408 @default.
- W4224529703 hasConcept C162324750 @default.
- W4224529703 hasConcept C175444787 @default.
- W4224529703 hasConcept C17744445 @default.
- W4224529703 hasConcept C191935318 @default.
- W4224529703 hasConcept C199539241 @default.
- W4224529703 hasConcept C2777364431 @default.
- W4224529703 hasConcept C2777995714 @default.
- W4224529703 hasConcept C2779951463 @default.
- W4224529703 hasConcept C2780879335 @default.
- W4224529703 hasConcept C2781249084 @default.
- W4224529703 hasConcept C2908524427 @default.
- W4224529703 hasConcept C2994186709 @default.
- W4224529703 hasConcept C3017709941 @default.
- W4224529703 hasConcept C3020729460 @default.
- W4224529703 hasConcept C71924100 @default.
- W4224529703 hasConcept C74909509 @default.
- W4224529703 hasConcept C95057490 @default.
- W4224529703 hasConceptScore W4224529703C121608353 @default.
- W4224529703 hasConceptScore W4224529703C126322002 @default.
- W4224529703 hasConceptScore W4224529703C144024400 @default.
- W4224529703 hasConceptScore W4224529703C149923435 @default.
- W4224529703 hasConceptScore W4224529703C151956035 @default.
- W4224529703 hasConceptScore W4224529703C159110408 @default.
- W4224529703 hasConceptScore W4224529703C162324750 @default.
- W4224529703 hasConceptScore W4224529703C175444787 @default.
- W4224529703 hasConceptScore W4224529703C17744445 @default.
- W4224529703 hasConceptScore W4224529703C191935318 @default.
- W4224529703 hasConceptScore W4224529703C199539241 @default.